Saturday 17 October 2026
Export NBTX’s income statement to Excel — free account
Nanobiotix S.A. - Sponsored ADR
NBTX Healthcare Biotechnology
21.30
0.93
−4.18%
Follow NBTX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 2 | 3 | 5 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2,115.07 | 2,115.07 | 2,115.07 | 2,115.07 | 2,557.11 | 1,617.86 | 741.02 | 1,468.06 | 573.24 | 4,617.90 |
Altman Z-Score |
— | — | — | — | 3.05 | 0.24 | (2.71) | 0.89 | — | 3.40 |
Altman Z″-Score (non-manufacturers) |
(8.31) | — | — | (4.87) | 3.72 | (0.98) | (7.11) | (0.70) | — | (2.30) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | 1.54 | 48.02 | (4.60) | 2.44 | — | — |
P/Operating CF |
(14.48) | (14.48) | (14.48) | (14.48) | (14.07) | (6.91) | (3.16) | (6.27) | (2.45) | (19.72) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 4.27 | 5.33 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 4.27 | 5.33 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2,239.44 | 2,239.44 | 2,239.44 | 2,239.44 | 1,917.58 | 1,146.44 | 803.15 | 1,167.28 | 537.50 | 4,526.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.81) | (3.81) | (3.81) | (3.81) | (2.22) | (1.21) | (0.75) | (1.35) | (0.94) | (5.56) |
EV/FCF |
(3.81) | (3.81) | (3.81) | (3.81) | (2.22) | (1.20) | (0.75) | (1.34) | (0.91) | (5.41) |
Quick Ratio |
3.16 | 5.57 | 3.58 | 2.45 | 6.26 | 2.38 | 1.09 | 1.53 | 0.89 | 0.95 |
Current Ratio |
3.26 | 5.68 | 3.68 | 3.22 | 6.58 | 2.53 | 1.38 | 1.75 | 1.04 | 1.09 |
Net Debt/EBITDA |
0.61 | 1.50 | 0.48 | 0.78 | 3.44 | 1.64 | 0.92 | 2.98 | 0.74 | 5.66 |
Debt/Assets |
18.79% | 0.00% | 44.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.33 | 0.11 | 1.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.03 | 0.02 | 0.00 | 0.05 | 0.03 | 0.02 | 0.05 | 0.48 | (0.09) | 0.49 |
Operating CF/Net income |
0.84 | 0.81 | 0.86 | 0.81 | 0.82 | 0.64 | 0.65 | 0.31 | 0.29 | 1.39 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.82) | (0.06) | (0.15) | (0.06) | (0.22) | (0.52) | (0.37) |
Interest Coverage |
(316.12) | (406.46) | (75.89) | (9.41) | 13.77 | (67.41) | (3.37) | (1.81) | (9.13) | (0.71) |
| (65.20%) | (89.17%) | (101.46%) | (812.85%) | (97.94%) | (99.13%) | (3,754.04%) | 281.84% | 201.73% | 32.53% | |
| (45.76%) | (198.42%) | (82.41%) | (98.45%) | (35.52%) | (40.66%) | (65.55%) | (52.21%) | (84.46%) | (36.24%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(103.82%) | (55.92%) | (89.41%) | (123.68%) | (29.35%) | (72.98%) | (264.79%) | (90.81%) | (844.36%) | (244.27%) |
Average Days of Receivables |
1,177.74 | 7,093.31 | 16,840.34 | 1.58 | 9.01 | 514.28 | 7.72 | 9.12 | (151.11) | 23.92 |
Research and Development Expense of Revenue |
1,064.28% | 6,337.18% | 17,550.86% | 1,196.82% | 968.54% | 1,147.63% | 683.33% | 106.05% | (563.77%) | 70.92% |
Selling, General and Administrative Expense of Revenue |
658.33% | 4,895.00% | 10,877.59% | 744.16% | 581.64% | 734.18% | 373.89% | 60.90% | (285.45%) | 62.47% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 170.01% | 116.40% | 120.93% | 66.46% | 8.90% | (59.77%) | 10.86% |
Graham Net Nets |
(0.10) | (0.10) | (0.10) | (0.10) | 0.20 | 0.13 | (0.47) | (0.06) | (1.30) | (0.21) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(27.79%) | (27.79%) | (27.79%) | (27.79%) | (25.87%) | (39.45%) | (89.51%) | (45.18%) | (115.71%) | (14.36%) |
Free Cash Flow Yield |
(27.80%) | (27.80%) | (27.80%) | (27.80%) | (33.78%) | (59.01%) | (144.50%) | (59.37%) | (103.52%) | (18.11%) |
Revenue per Share |
0.11 | 0.02 | 0.01 | 0.13 | 0.12 | 0.09 | 0.14 | 1.06 | (0.16) | 0.77 |
Operating CF per Share |
(1.26) | (1.46) | (1.13) | (2.13) | (1.29) | (1.02) | (1.12) | (0.37) | (0.45) | (0.79) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.07) | 0.00 | (0.01) | 0.00 | (0.01) | (0.02) | (0.01) |
Free Cash Flow per Share |
(1.26) | (1.46) | (1.13) | (2.21) | (1.29) | (1.03) | (1.12) | (0.38) | (0.47) | (0.80) |
Cash per Share |
1.45 | 3.25 | 1.57 | 1.82 | 5.58 | 2.86 | 1.25 | 2.21 | 1.14 | 1.25 |
Shareholders Equity per Share |
1.18 | 3.01 | 0.61 | (0.10) | 3.30 | 0.91 | (0.82) | (0.05) | (1.50) | (2.00) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.18 | 3.01 | 0.61 | (0.10) | 3.30 | 0.91 | (0.82) | (0.05) | (1.50) | (2.00) |
Free Cash Flow |
(19.32) | (25.47) | (29.87) | (47.73) | (31.58) | (35.62) | (39.19) | (13.87) | (22.07) | (38.43) |
Working Capital |
19.63 | 52.72 | 35.69 | 35.59 | 121.32 | 66.51 | 15.20 | 40.55 | 2.74 | 5.93 |
Capital Expenditures |
(0.42) | (1.76) | (0.58) | (1.62) | (0.12) | (0.28) | (0.10) | (0.36) | (0.92) | (0.62) |
Net Current Asset Value |
14.62 | 47.67 | 12.30 | (13.42) | 70.46 | 21.39 | (36.30) | (9.09) | (77.54) | (101.25) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.57 | 0.04 | 0.09 | 0.02 | 0.01 | (0.12) | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.14 | 0.21 | 0.19 | 0.21 | 0.19 | 0.21 | 0.24 | 0.29 | 0.33 |
Cash ROIC |
(41.83%) | (22.12%) | (36.71%) | (128.41%) | (14.58%) | (27.19%) | (259.34%) | (17.45%) | 127.76% | 107.04% |
Accounts Receivable Turnover |
0.29 | 0.05 | 0.02 | 0.92 | 69.06 | 1.40 | 2.23 | 72.17 | (3.70) | 13.08 |
Accounts Payable Turnover |
0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | — | — | — | — | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 5,432.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | — | — | — | — | 0.00 | — | — | — |
Average Receivables |
5.60 | 5.60 | 6.03 | 3.08 | 0.04 | 2.24 | 2.26 | 0.54 | 2.10 | 2.82 |
Average Payables |
5.40 | 5.40 | 6.84 | 8.09 | 8.41 | 7.89 | 8.90 | 14.94 | 20.71 | 16.00 |
Average Assets |
50.33 | 15.87 | 42.32 | 57.92 | 108.03 | 136.75 | 91.69 | 82.30 | 87.29 | 74.81 |
Average Common Equity |
35.32 | 35.32 | 34.38 | 7.02 | 39.18 | 56.10 | 1.60 | (15.25) | (36.55) | (83.34) |
Columns are period end dates · fundamentals updated 28 Sep 2026